← Leaderboards
Serge P Nana-Sinkam
University Of Colorado Denver
$9,134,974
Attributed
$17,409,787
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,409,787 · 11
By mechanism
R01$4,661,861 · 2
KL2$3,714,720 · 1
U01$2,664,982 · 1
K12$2,248,386 · 1
UG1$2,173,286 · 1
R21$720,850 · 2
Top collaborators
- Ly James Lee7 shared
- Arun J Sanyal6 shared
- Carlo M Croce5 shared
- Philip T Diaz5 shared
- Rebecca Kaltman3 shared
- Alexander H Krist3 shared
- Gretchen N Neigh2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Raphael A. Nemenoff$15,000,654
- Mark W Geraci$20,364,365
- Rubin M Tuder$19,596,454
- Kurt R Stenmark$22,132,904
- Mark Robert Nicolls$22,256,364
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMicrornasBaseInnovationCessation Of LifeMolecularMalignant NeoplasmsPatternEarly DiagnosisMalignant Neoplasm Of LungUniversitiesCancer EtiologyLungProgramsSmokerEnvironmentStatisticsUnited States National Institutes Of HealthProteinsResearch PersonnelBiological MarkersCellsDesignDiscipline
Grant awards (40)
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)$806,066
UG1 · FY2025 · CA
CTSA K12 Program at Virginia Commonwealth University$749,462
K12 · FY2025 · TR · contact PI
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)$502,745
UG1 · FY2025 · CA
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)$864,475
UG1 · FY2024 · CA
CTSA K12 Program at Virginia Commonwealth University$749,462
K12 · FY2024 · TR · contact PI
CTSA K12 Program at Virginia Commonwealth University$749,462
K12 · FY2023 · TR · contact PI
Project 1: Lung Cancer$136,657
P20 · FY2023 · CA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2022 · TR · contact PI
Project 1: Lung Cancer$132,883
P20 · FY2022 · CA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2021 · TR · contact PI
Extracellular Vesicles in Small Cell Lung Cancer Early Detection$496,494
U01 · FY2021 · CA · contact PI
Project 1: Lung Cancer$148,712
P20 · FY2021 · CA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2020 · TR · contact PI
Extracellular Vesicles in Small Cell Lung Cancer Early Detection$492,386
U01 · FY2020 · CA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2019 · TR · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$495,822
R01 · FY2019 · DA
Extracellular Vesicles in Small Cell Lung Cancer Early Detection$469,149
U01 · FY2019 · CA · contact PI
Molecular Mechanisms of Cachexia in Lung Cancer$416,213
R01 · FY2019 · CA
Institutional Career Development Core$742,944
KL2 · FY2018 · TR · contact PI
Extracellular Vesicles in Small Cell Lung Cancer Early Detection$593,585
U01 · FY2018 · CA · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$503,540
R01 · FY2018 · DA
Molecular Mechanisms of Cachexia in Lung Cancer$429,084
R01 · FY2018 · CA
Extracellular Vesicles in Small Cell Lung Cancer Early Detection$613,368
U01 · FY2017 · CA · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$516,715
R01 · FY2017 · DA
Molecular Mechanisms of Cachexia in Lung Cancer$429,084
R01 · FY2017 · CA
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$500,087
R01 · FY2016 · DA
Molecular Mechanisms of Cachexia in Lung Cancer$429,084
R01 · FY2016 · CA
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$513,148
R01 · FY2015 · DA
Molecular Mechanisms of Cachexia in Lung Cancer$429,084
R01 · FY2015 · CA
Plasma RNA based Early Lung Cancer Detection by Tethered Cationic Lipoplex Assay$194,941
R21 · FY2014 · CA
Plasma RNA based Early Lung Cancer Detection by Tethered Cationic Lipoplex Assay$167,022
R21 · FY2013 · CA
MicroRNA Expression in Lung Cancer Development and Progression$193,043
R21 · FY2011 · CA · contact PI
MicroRNA Expression in Lung Cancer Development and Progression$165,844
R21 · FY2010 · CA · contact PI
Integration of transcriptosome and microRNome in Understanding COPD Phenotypes$75,000
R03 · FY2009 · HL · contact PI
Regulation of Prostacyclin in Pulmonary Hypertension$131,490
K08 · FY2008 · HL · contact PI
Integration of transcriptosome and microRNome in Understanding COPD Phenotypes$75,000
R03 · FY2008 · HL · contact PI
Regulation of Prostacyclin in Pulmonary Hypertension$131,490
K08 · FY2007 · HL · contact PI
Regulation of Prostacyclin in Pulmonary Hypertension$131,490
K08 · FY2006 · HL · contact PI
Regulation of Prostacyclin in Pulmonary Hypertension$131,490
K08 · FY2005 · HL
Regulation of Prostacyclin in Pulmonary Hypertension$131,490
K08 · FY2004 · HL